Rubra Medicaments reports standalone nil net profit/loss in the June 2016 quarter
Sales reported at Rs 0.07 crore
Rubra Medicaments reported no net profit/loss in the quarter ended June 2016 as against net loss of Rs 0.01 crore during the previous quarter ended June 2015. Sales reported to Rs 0.07 crore in the quarter ended June 2016. There were no Sales reported during the previous quarter ended June 2015. ParticularsQuarter EndedJun. 2016Jun. 2015% Var.Sales0.070 0 OPM %00 -PBDT0-0.01 100 PBT0-0.01 100 NP0-0.01 100Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content